ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments
RAMSEY, N.J. and BOCA RATON, Fla., May 07, 2020 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end […]
Intra-Cellular Therapies Reports First Quarter 2020 Financial Results and Provides Corporate Update
NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development […]
Otonomy Reports First Quarter 2020 Financial Results and Provides Corporate Update
SAN DIEGO, May 07, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative […]
Intellia Therapeutics Announces First Quarter 2020 Financial Results
On track to submit an IND or IND-equivalent for NTLA-2001 for the treatment of transthyretin amyloidosis in mid-2020; plans to […]
Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update
Pending Merger with Lantheus Holdings, Inc. for Combination of an Innovative Commercial Life Sciences Company with a Diversified Precision Diagnostics […]
Ovid Therapeutics Announces Positive Topline Results from the Phase 2 ROCKET Trial of OV101 for the Treatment of Fragile X Syndrome
OV101 met the study’s primary objective of safety and tolerabilityOV101 produced statistically significant reductions in behavioral and functional symptoms in […]
CloudMD Partners with Innovative Technology Leader IDYA4 Corp. to Expand Telemedicine Solutions into the United States
VANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (CSE: DOC, OTCQB: DOCRF, Frankfurt: 6PH) […]
CB2 Insights Announces Unaudited Profitability in April and Continued Execution of its Business Plan
TORONTO, May 07, 2020 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), has announced that it […]
resTORbio Provides Corporate Update and Reports First Quarter 2020 Financial Results
BOSTON, May 07, 2020 (GLOBE NEWSWIRE) — resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target […]
Kura Oncology to Present at BofA Securities Virtual Health Care Conference 2020
SAN DIEGO, May 07, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing […]
